AMPKβ isoform expression patterns in various adipocyte models and in relation to body mass index

AMP-activated protein kinase (AMPK) activation is considered a useful strategy for the treatment of type 2 diabetes (T2D). It is unclear whether the expression and/or activity of AMPK in adipocytes is dysregulated in obesity. Also, the expression/activity pattern of AMPKβ isoforms, which are targets...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in physiology Vol. 13; p. 928964
Main Authors Kopietz, Franziska, Degerman, Eva, Göransson, Olga
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 04.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:AMP-activated protein kinase (AMPK) activation is considered a useful strategy for the treatment of type 2 diabetes (T2D). It is unclear whether the expression and/or activity of AMPK in adipocytes is dysregulated in obesity. Also, the expression/activity pattern of AMPKβ isoforms, which are targets for AMPK activators, in adipocytes remains elusive. In this study we show that the two AMPKβ isoforms make roughly equal contributions to AMPK activity in primary human and mouse adipocytes, whereas in cultured 3T3-L1 adipocytes of mouse origin and in primary rat adipocytes, β1-associated activity clearly dominates. Additionally, we found that obesity is not associated with changes in AMPK subunit expression or kinase activity in adipocytes isolated from subcutaneous adipose tissue from individuals with various BMI.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Naresh Chandra Bal, KIIT University, India
This article was submitted to Metabolic Physiology, a section of the journal Frontiers in Physiology
Reviewed by: Luc Bertrand, Catholic University of Louvain, Belgium
Benoit Viollet, Institut National de la Santé et de la Recherche Médicale (INSERM), France
ISSN:1664-042X
1664-042X
DOI:10.3389/fphys.2022.928964